L

LiMM Therapeutics

10 employees

LiMM Therapeutics is a biopharmaceutical company that harnesses the molecular cross-talk between neuronal and innate lymphoid cells.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Therapeutics
Medical Device
Health Care

Date founded

2018

Funding rounds raised

Total raised

$2.9M

from 5 investors over 5 rounds

L

LiMM Therapeutics raised undisclosed on July 15, 2020

Investors: Portugal Ventures

L

LiMM Therapeutics raised $2.3M on April 12, 2019

Investors: Seventure Partners and PMEInvestimentos

L

LiMM Therapeutics raised $2.9M on June 25, 2018

Investors: 200M Fund and Seventure Partners

FAQ